» Authors » Michio Inukai

Michio Inukai

Explore the profile of Michio Inukai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 461
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Inukai M, Ohara A, Nasu J, Kawai H, Watanabe K, Watanabe H, et al.
Gan To Kagaku Ryoho . 2022 Jul; 49(7):775-778. PMID: 35851349
Weight loss during cancer chemotherapy affects the continuation of treatment; therefore, it is important to maintain and improve nutritional status. Additionally, appropriate fluid and electrolyte replacement is essential for maintaining...
2.
Satake H, Hashida H, Tanioka H, Miyake Y, Yoshioka S, Watanabe T, et al.
Oncologist . 2021 May; 26(7):e1125-e1132. PMID: 33977607
Lessons Learned: Three-month adjuvant capecitabine plus oxaliplatin in combination (CAPOX) appeared to reduce recurrence, with mild toxicity in postcurative resection of colorectal cancer liver metastases (CLM). Recurrence in patients who...
3.
Shinozaki K, Yamada T, Nasu J, Matsumoto T, Yuasa Y, Shiraishi T, et al.
Int J Clin Oncol . 2020 Oct; 26(2):399-408. PMID: 33097971
Purpose: FOLFOXIRI plus bevacizumab is regarded as a first-line therapeutic option for selected patients with metastatic colorectal cancer (mCRC). Our aim was to assess the efficacy and safety of induction...
4.
Maruyama M, Iijima S, Ishibashi N, Inukai M, Oriishi T, Kawasaki N, et al.
Ann Nutr Metab . 2018 Sep; 73(3):169-176. PMID: 30179861
Background/aims: The current study was undertaken to assess if the semi-solid formulas could be used with a new ENFit connector with similar force to current percutaneous endoscopic gastrostomy (PEG) tubes....
5.
Tsuruta A, Yamashita K, Tanioka H, Tsuji A, Inukai M, Yamakawa T, et al.
Drug Des Devel Ther . 2016 Dec; 10:3827-3835. PMID: 27920498
Background: Six months of oxaliplatin-based chemotherapy is the standard adjuvant chemotherapy for completely resected stage III colorectal cancer (CRC). Also, patients with stage II CRC who are considered to be...
6.
Nagasaka T, Mishima H, Sawaki A, Shimokawa M, Inukai M, Shinozaki K, et al.
BMJ Open . 2016 Jun; 6(6):e011454. PMID: 27256093
Introduction: Results from several randomised trials suggest that the sequential use of cytotoxic agents in patients with metastatic colorectal cancer (mCRC) has the potential to improve overall survival compared with...
7.
Masugata H, Senda S, Inukai M, Himoto T, Hosomi N, Okada H, et al.
Exp Ther Med . 2014 Jun; 8(1):21-24. PMID: 24944591
The present study aimed to investigate the association between plasma brain natriuretic peptide (BNP) levels and systolic blood pressure (SBP) variability over a one-year period. Blood pressure was measured in...
8.
Himoto T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Kurokohchi K, et al.
Diabetol Metab Syndr . 2013 Sep; 5(1):51. PMID: 24016701
Background: CD36, a class B scavenger receptor, participates in the pathogenesis of metabolic dysregulation such as insulin resistance, hepatic steatosis, and atherosclerosis. Persistent hepatitis C virus (HCV) infection often evokes...
9.
Masugata H, Senda S, Inukai M, Himoto T, Hosomi N, Murao K, et al.
Clin Exp Hypertens . 2013 Jul; 36(4):258-62. PMID: 23848250
Cardio-ankle vascular index (CAVI) has been demonstrated as a parameter of arterial stiffness, which antihypertensive therapy may improve. However, little information is available about the factors affecting changes in arterial...
10.
Masugata H, Senda S, Inukai M, Himoto T, Hosomi N, Murao K, et al.
J Int Med Res . 2013 Jun; 41(4):1272-80. PMID: 23735237
Objectives: To elucidate the clinical significance of differences between home- and clinic-measured systolic blood pressure (SBP) in patients with treated hypertension, and to assess the correlations between SBPs and arterial...